| Shares Outstanding | 59,074,391 shares |
| Insider Shares | 15,902,852 shares |
| Insider Ownership | 26.92 % |
| Total Insiders | 26 |
Insider Sentiment Score
The Insider Sentiment Score finds the companies being bought by corporate insiders.
It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of insider accumulation. The scoring model uses a combination of the net number of insiders buying the prior 90 days, the total shares bought as a percentage of float, and the total shares owned by insiders. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.
Update Frequency: Daily
See Insiders Top Picks, which provides a list of companies with highest insider accumulation.
Officer Sentiment Score
The Officer Sentiment Score finds companies being bought by Corporate Officers.
By definition Corporate Officers are Corporate Insiders, but unlike some of the other Insiders (10% Shareholders and Board Members), Officers work for the company on a daily basis, and they user their own money when trading. (10% Shareholders and Board Members are often fund managers managing other people’s money.) As such, insider trades made by Officers are much more significant and should be treated appropriately.
Like the Insider Sentiment Score, the Officer Sentiment Score is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of officer accumulation.
Update Frequency: Daily
See Insiders Top Picks, which provides a list of companies with highest insider sentiment.
Key Insider Metrics
This card shows how the company ranks along various insider metrics. The percentile rank shows how this company compares to other companies in the US markets. Higher rankings are indicative of better situations.
For example, it is generally accepted that insider buying is a positive indicator, so companies with more insider buying would rank higher than companies with less insider buying (or even insider selling).
Insider Trading Chart
Cullinan Therapeutics, Inc. insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Roster and Profitability Metrics
This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.
See our leaderboard of most profitable insider traders.
| Insider | Avg Profit (%) | Shares Owned |
Split Adjusted |
|---|---|---|---|
| Nadim Ahmed President and CEO, Director - [D] [O] | 430,621 | 430,621 | |
|
Bvf Partners L P/il
10% Owner -
|
64,161 | 64,161 | |
| Patrick Baeuerle Chief Scientific Officer - [O] | 417,434 | 417,434 | |
| Thomas Ebeling Director - [D] | 186,653 | 186,653 | |
|
Bioscience I 2017 Ltd F2
10% Owner -
|
537,392 | 537,392 | |
|
F2 Gc, Llc
10% Owner -
|
104,762 | 104,762 | |
|
Vision SCS F2
10% Owner -
|
4,476,350 | 4,476,350 | |
| Mary Kay Fenton Chief Financial Officer - [O] | 60,000 | 60,000 |
| Insider | Avg Profit (%) | Shares Owned |
Split Adjusted |
|---|---|---|---|
|
Ansbert Gadicke
10% Owner -
|
595,489 | 595,489 | |
| Owen Hughes President and CEO, Director - [D] [O] | 506,226 | 506,226 | |
| Jeffrey Alan Jones Chief Medical Officer - [O] | 174,164 | 174,164 | |
|
Morana Jovan-Embiricos
10% Owner -
|
207,803 | 4,476,350 | |
| Raymond T Keane Chief Legal Officer - [O] | 24,124 | 24,124 | |
|
Mark N Lampert
10% Owner -
|
319,415 | 64,161 | |
|
MPM Oncology Impact Management LP
10% Owner -
|
7,648,268 | 7,648,268 | |
| Anne-Marie Martin | 36,880 | ||
| Jennifer Michaelson Chief Scientific Officer - [O] | 142,004 | 142,004 |
| Insider | Avg Profit (%) | Shares Owned |
Split Adjusted |
|---|---|---|---|
| Nate Nguyen Interim PAO and PFO - [O] | 13,375 | 13,375 | |
| Anthony Rosenberg Director - [D] | 45,002 | 45,002 | |
| Jacquelyn L Sumer Chief Legal Officer - [O] | 136,895 | 136,895 | |
| Corrine Savill Chief Business Officer - [O] | 240,990 | 240,990 | |
| Jeffrey Trigilio Chief Financial Officer - [O] | 133,919 | 133,919 | |
|
UBS Oncology Impact Fund L.P.
10% Owner -
|
7,648,268 | 7,648,268 | |
| Stephen W Webster | 7,800 | ||
| Jon Marc Wigginton | 116,666 | ||
| Leigh Zawel See Remarks - [O] | 69,785 | 69,785 |
Report errors via our new Insider Auditing Tool
Track Records of Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made in CGEM / Cullinan Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Track Records of Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in CGEM / Cullinan Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .
The following table shows the most recent open market sales that were not part of an automatic trading plan.
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Transaction History
Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-27 | 2025-02-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8.5300 | -3,756 | -32 | 142,004 | ||||
| 2025-02-27 | 2025-02-25 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 8.5300 | -3,756 | -32 | 136,895 | ||||
| 2025-02-27 | 2025-02-25 | 4 | AHMED NADIM | CGEM | Common Stock | D | 8.5300 | -12,529 | -107 | 430,621 | ||||
| 2025-02-27 | 2025-02-25 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 8.5300 | -4,895 | -42 | 174,164 | ||||
| 2025-02-21 | 2025-02-19 | 4 | Fenton Mary Kay | CGEM | Common Stock | D | 60,000 | 60,000 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 65,000 | 179,059 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | AHMED NADIM | CGEM | Common Stock | D | 180,000 | 443,150 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 50,000 | 140,651 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | Savill Corrine | CGEM | Common Stock | D | 37,500 | 240,990 | ||||||
| 2025-02-21 | 2025-02-19 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 50,000 | 145,760 | ||||||
| 2025-01-07 | 2025-01-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12.5100 | -4,000 | -50 | 95,760 | ||||
| 2024-12-27 | 2024-12-24 | 4 | AHMED NADIM | CGEM | Common Stock | D | 11.8700 | -8,400 | -100 | 263,150 | ||||
| 2024-12-20 | 2024-12-18 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 11.4100 | -3,482 | -40 | 90,651 | ||||
| 2024-12-20 | 2024-12-18 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 11.4100 | -4,632 | -53 | 114,059 | ||||
| 2024-12-20 | 2024-12-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 11.4100 | -4,693 | -54 | 99,760 | ||||
| 2024-12-16 | 2024-12-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12.5200 | -3,489 | -44 | 104,453 | ||||
| 2024-11-07 | 2024-11-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 15.6400 | -8,000 | -125 | 107,942 | ||||
| 2024-09-09 | 2024-09-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 18.0900 | -8,000 | -145 | 115,942 | ||||
| 2024-07-09 | 2024-07-05 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 16.3300 | -8,000 | -131 | 123,942 | ||||
| 2024-07-02 | 2024-07-01 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 9.0000 | 2,360 | 21 | 131,942 | ||||
| 2024-06-11 | 2024-06-10 | 4 | Ebeling Thomas | CGEM | Common Stock | D | 13.0000 | 18,450 | 240 | 186,653 | ||||
| 2024-05-23 | 2024-05-23 | 4 | Ebeling Thomas | CGEM | Common Stock | D | 12.7300 | 16,475 | 210 | 168,203 | ||||
| 2024-05-23 | 2024-05-23 | 4 | Ebeling Thomas | CGEM | Common Stock | D | 4.3000 | 84,224 | 362 | 151,728 | ||||
| 2024-05-08 | 2024-05-07 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 30.0600 | -5,606 | -169 | 129,582 | ||||
| 2024-05-08 | 2024-05-07 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 5,606 | 24 | 135,188 | ||||
| 2024-05-08 | 2024-05-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 28.5400 | -20,277 | -579 | 129,582 | ||||
| 2024-05-08 | 2024-05-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 27.8200 | -37,723 | -1,049 | 149,859 | ||||
| 2024-05-08 | 2024-05-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 50,000 | 215 | 187,582 | ||||
| 2024-04-02 | 3 | Nguyen Nate | CGEM | Common Stock | D | 13,375 | ||||||||
| 2024-04-02 | 3 | Nguyen Nate | CGEM | Common Stock | D | 13,375 | ||||||||
| 2024-04-02 | 3 | Nguyen Nate | CGEM | Common Stock | D | 6,250 | ||||||||
| 2024-02-23 | 2024-02-22 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 50,000 | 137,582 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 62,500 | 118,691 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | AHMED NADIM | CGEM | Common Stock | D | 160,000 | 271,550 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | Savill Corrine | CGEM | Common Stock | D | 37,500 | 203,490 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 50,000 | 94,133 | ||||||
| 2024-02-23 | 2024-02-22 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 50,000 | 133,919 | ||||||
| 2024-02-02 | 2024-02-01 | 4 | Savill Corrine | CGEM | Common Stock | D | 16.1800 | -40,000 | -647 | 165,990 | ||||
| 2024-02-02 | 2024-02-01 | 4 | Savill Corrine | CGEM | Common Stock | D | 4.3000 | 40,000 | 172 | 205,990 | ||||
| 2024-01-30 | 2024-01-29 | 4 | Savill Corrine | CGEM | Common Stock | D | 14.0900 | -40,000 | -564 | 165,990 | ||||
| 2024-01-30 | 2024-01-29 | 4 | Savill Corrine | CGEM | Common Stock | D | 4.3000 | 40,000 | 172 | 205,990 | ||||
| 2024-01-24 | 2024-01-23 | 4 | Savill Corrine | CGEM | Common Stock | D | 12.4600 | -21,316 | -266 | 165,990 | ||||
| 2024-01-24 | 2024-01-23 | 4 | Savill Corrine | CGEM | Common Stock | D | 4.3000 | 21,316 | 92 | 187,306 | ||||
| 2024-01-24 | 2024-01-22 | 4 | Savill Corrine | CGEM | Common Stock | D | 12.0200 | -4,125 | -50 | 165,990 | ||||
| 2024-01-24 | 2024-01-22 | 4 | Savill Corrine | CGEM | Common Stock | D | 12.1800 | -14,559 | -177 | 170,115 | ||||
| 2024-01-24 | 2024-01-22 | 4 | Savill Corrine | CGEM | Common Stock | D | 4.3000 | 14,559 | 63 | 184,674 | ||||
| 2023-12-27 | 2023-12-26 | 4 | AHMED NADIM | CGEM | Common Stock | D | 9.2400 | -4,272 | -39 | 111,550 | ||||
| 2023-12-22 | 2023-12-21 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 8.5000 | -1,400 | -12 | 44,133 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 8.5000 | -1,860 | -16 | 56,191 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8.5000 | -1,920 | -16 | 83,919 | ||||
| 2023-12-22 | 2023-12-21 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8.5000 | -1,145 | -10 | 87,582 | ||||
| 2023-12-20 | 2023-12-18 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 8.2200 | -290 | -2 | 45,533 | ||||
| 2023-12-20 | 2023-12-18 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8.2200 | -398 | -3 | 85,839 | ||||
| 2023-12-20 | 2023-12-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8.2200 | -238 | -2 | 88,727 | ||||
| 2023-12-20 | 2023-12-18 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 8.2200 | -386 | -3 | 58,051 | ||||
| 2023-12-13 | 2023-12-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 7.8100 | -1,068 | -8 | 88,965 | ||||
| 2023-12-13 | 2023-12-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 7.8100 | -1,926 | -15 | 86,237 | ||||
| 2023-07-05 | 2023-06-30 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 9.0800 | 2,340 | 21 | 88,163 | ||||
| 2023-06-29 | 2023-06-28 | 4 | AHMED NADIM | CGEM | Common Stock | D | 11.4000 | -759 | -9 | 115,822 | ||||
| 2023-06-21 | 2023-06-20 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 12.9400 | -399 | -5 | 85,823 | ||||
| 2023-06-21 | 2023-06-20 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 12.9400 | -291 | -4 | 45,823 | ||||
| 2023-06-21 | 2023-06-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12.9400 | -238 | -3 | 90,033 | ||||
| 2023-06-21 | 2023-06-20 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 12.9400 | -387 | -5 | 58,437 | ||||
| 2023-06-14 | 2023-06-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 13.1100 | -176 | -2 | 90,271 | ||||
| 2023-06-14 | 2023-06-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 13.1100 | -319 | -4 | 86,222 | ||||
| 2023-06-08 | 2023-06-07 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12.4000 | -100 | -1 | 90,447 | ||||
| 2023-06-08 | 2023-06-07 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 100 | 0 | 90,547 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12.3100 | -11,900 | -146 | 90,447 | ||||
| 2023-06-08 | 2023-06-06 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 11,900 | 51 | 102,347 | ||||
| 2023-05-24 | 2023-05-23 | 4 | AHMED NADIM | CGEM | Common Stock | D | 9.1500 | -707 | -6 | 116,581 | ||||
| 2023-05-19 | 2023-05-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8.7600 | -239 | -2 | 90,447 | ||||
| 2023-05-19 | 2023-05-18 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 8.7600 | -394 | -3 | 58,824 | ||||
| 2023-05-19 | 2023-05-18 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8.7600 | -399 | -3 | 86,541 | ||||
| 2023-05-19 | 2023-05-18 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 8.7600 | -291 | -3 | 46,114 | ||||
| 2023-05-16 | 2023-05-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 8.7800 | -193 | -2 | 90,686 | ||||
| 2023-05-16 | 2023-05-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8.7800 | -347 | -3 | 86,940 | ||||
| 2023-04-26 | 2023-04-25 | 4 | AHMED NADIM | CGEM | Common Stock | D | 10.5900 | -716 | -8 | 117,288 | ||||
| 2023-04-20 | 2023-04-18 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 10.7100 | -392 | -4 | 59,218 | ||||
| 2023-04-20 | 2023-04-18 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 10.7100 | -398 | -4 | 87,287 | ||||
| 2023-04-20 | 2023-04-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 10.7100 | -238 | -3 | 90,879 | ||||
| 2023-04-20 | 2023-04-18 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 10.7100 | -290 | -3 | 46,405 | ||||
| 2023-04-14 | 2023-04-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 10.2200 | -318 | -3 | 87,685 | ||||
| 2023-04-14 | 2023-04-12 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 10.2200 | -176 | -2 | 91,117 | ||||
| 2023-03-27 | 2023-03-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 11.3200 | -238 | -3 | 91,293 | ||||
| 2023-03-27 | 2023-03-23 | 4 | AHMED NADIM | CGEM | Common Stock | D | 10.5100 | -706 | -7 | 118,004 | ||||
| 2023-03-27 | 2023-03-20 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 11.3200 | -390 | -4 | 59,610 | ||||
| 2023-03-27 | 2023-03-20 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 11.3200 | -305 | -3 | 46,695 | ||||
| 2023-03-27 | 2023-03-20 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 11.3200 | -399 | -5 | 88,003 | ||||
| 2023-02-23 | 2023-02-22 | 4 | AHMED NADIM | CGEM | Common Stock | D | 109,000 | 118,710 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 38,500 | 76,000 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 47,000 | 88,402 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | SUMER JACQUELYN L | CGEM | Common Stock | D | 47,000 | 47,000 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Savill Corrine | CGEM | Common Stock | D | 20,500 | 170,115 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 38,500 | 91,531 | ||||||
| 2023-02-21 | 2023-02-17 | 4 | Jones Jeffrey Alan | CGEM | Common Stock | D | 60,000 | 60,000 | ||||||
| 2023-02-10 | 2021-12-21 | 5 | GADICKE ANSBERT | CGEM | Common Stock | D | 4.3000 | 350,938 | 1,509 | 595,489 | ||||
| 2023-01-19 | 2023-01-19 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | -300,000 | 64,161 | ||||||
| 2023-01-19 | 2023-01-19 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | -2,600,000 | 392,808 | ||||||
| 2023-01-19 | 2023-01-19 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | -3,500,000 | 558,854 | ||||||
| 2023-01-06 | 2022-12-30 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 8.9700 | 201 | 2 | 41,402 | ||||
| 2022-11-29 | 2022-11-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 13.3000 | -4,000 | -53 | 53,031 | ||||
| 2022-11-29 | 2022-11-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 4,000 | 17 | 57,031 | ||||
| 2022-09-29 | 2022-09-27 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 12.4000 | -4,000 | -50 | 53,031 | ||||
| 2022-09-29 | 2022-09-27 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 4,000 | 17 | 57,031 | ||||
| 2022-08-09 | 2022-08-08 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 15.0100 | -1,385 | -21 | 53,031 | ||||
| 2022-08-09 | 2022-08-08 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 1,385 | 6 | 54,416 | ||||
| 2022-08-04 | 2022-08-04 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 14.3056 | -25,989 | -372 | 1,255,963 | ||||
| 2022-08-04 | 2022-08-03 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 14.2367 | -19,129 | -272 | 1,281,952 | ||||
| 2022-08-04 | 2022-08-02 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 14.0973 | -4,792 | -68 | 1,301,081 | ||||
| 2022-07-26 | 2022-07-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 14.5100 | -8,000 | -116 | 53,031 | ||||
| 2022-07-26 | 2022-07-25 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 8,000 | 34 | 61,031 | ||||
| 2022-07-21 | 2022-07-19 | 4 | Savill Corrine | CGEM | Common Stock | D | 15.2200 | -14,958 | -228 | 149,615 | ||||
| 2022-07-21 | 2022-07-18 | 4 | Savill Corrine | CGEM | Common Stock | D | 15.0600 | -5,042 | -76 | 164,573 | ||||
| 2022-07-12 | 2022-07-11 | 4 | Savill Corrine | CGEM | Common Stock | D | 13.8500 | -200 | -3 | 169,615 | ||||
| 2022-07-12 | 2022-07-11 | 4 | Savill Corrine | CGEM | Common Stock | D | 13.3300 | -39,800 | -531 | 169,815 | ||||
| 2022-07-05 | 2022-06-30 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 10.9000 | 1,620 | 18 | 53,031 | ||||
| 2022-07-05 | 2022-06-30 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 10.9000 | 1,451 | 16 | 41,201 | ||||
| 2022-07-05 | 2022-06-30 | 4 | AHMED NADIM | CGEM | Common Stock | D | 10.9000 | 1,620 | 18 | 9,710 | ||||
| 2022-06-28 | 2022-06-24 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | D | 13.3900 | -45,078 | -604 | 207,803 | ||||
| 2022-06-28 | 2022-06-24 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | D | 4.3000 | 35,529 | 153 | 252,881 | ||||
| 2022-06-28 | 2022-06-24 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | D | 4.3000 | 104,845 | 451 | 217,352 | ||||
| 2022-06-23 | 2022-06-23 | 4 | F2 Bioscience I 2017 Ltd | CGEM | Common Stock | D | 13.0036 | -29,631 | -385 | 537,392 | ||||
| 2022-06-23 | 2022-06-22 | 4 | F2 Bioscience I 2017 Ltd | CGEM | Common Stock | D | 12.7035 | -49,953 | -635 | 567,023 | ||||
| 2022-06-23 | 2022-06-21 | 4 | F2 Bioscience I 2017 Ltd | CGEM | Common Stock | D | 12.7662 | -22,319 | -285 | 616,976 | ||||
| 2022-06-07 | 2022-06-06 | 4 | AHMED NADIM | CGEM | Common Stock | D | 12.4000 | 8,090 | 100 | 8,090 | ||||
| 2022-06-03 | 2022-06-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10.9994 | 44,746 | 492 | 364,161 | ||||
| 2022-06-03 | 2022-06-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10.9994 | 301,009 | 3,311 | 2,992,808 | ||||
| 2022-06-03 | 2022-06-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10.9994 | 405,641 | 4,462 | 4,058,854 | ||||
| 2022-05-16 | 2022-05-16 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 11.2301 | -35,158 | -395 | 1,305,873 | ||||
| 2022-05-16 | 2022-05-13 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 10.4810 | -34,189 | -358 | 1,341,031 | ||||
| 2022-05-16 | 2022-05-13 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 9.9631 | -85,319 | -850 | 1,375,220 | ||||
| 2022-05-16 | 2022-05-12 | 4 | F2 Vision SCS | CGEM | Common Stock | D | 9.2497 | -264,072 | -2,443 | 1,460,539 | ||||
| 2022-05-16 | 2022-05-13 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9.1350 | 17,744 | 162 | 319,415 | ||||
| 2022-05-16 | 2022-05-13 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9.1350 | 38,558 | 352 | 2,691,799 | ||||
| 2022-05-16 | 2022-05-13 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9.1350 | 53,598 | 490 | 3,653,213 | ||||
| 2022-05-16 | 2022-05-12 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9.0600 | 457,001 | 4,140 | 2,653,241 | ||||
| 2022-05-16 | 2022-05-12 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 9.0600 | 542,999 | 4,920 | 3,599,615 | ||||
| 2022-04-05 | 2022-04-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10.7499 | 9,402 | 101 | 2,196,240 | ||||
| 2022-04-05 | 2022-04-01 | 4 | BVF PARTNERS L P/IL | CGEM | Common Stock | D | 10.7499 | 266,598 | 2,866 | 3,056,616 | ||||
| 2022-03-25 | 2021-09-16 | 4 | Ebeling Thomas | CGEM | Stock Option (Right to Buy) | D | 28.80 | 7,800 | 7,800 | |||||
| 2022-03-25 | 2021-09-16 | 4 | Rosenberg Anthony | CGEM | Stock Option (Right to Buy) | D | 28.80 | 7,800 | 7,800 | |||||
| 2022-03-25 | 2021-09-16 | 4 | Webster Stephen W | CGEM | Stock Option (Right to Buy) | D | 28.80 | 7,800 | 7,800 | |||||
| 2022-03-25 | 2021-09-16 | 4 | Jovan-Embiricos Morana | CGEM | Stock Option (Right to Buy) | D | 28.80 | 7,800 | 7,800 | |||||
| 2022-03-25 | 2021-09-16 | 4 | GADICKE ANSBERT | CGEM | Stock Option (Right to Buy) | D | 28.80 | 7,800 | 7,800 | |||||
| 2022-03-07 | 2022-03-05 | 4 | AHMED NADIM | CGEM | Performance Stock Unit | D | 215,000 | 215,000 | ||||||
| 2022-03-02 | 2022-03-01 | 4 | Martin Anne-Marie | CGEM | Stock Option (Right to Buy) | D | 13.99 | 36,880 | 36,880 | |||||
| 2022-03-02 | 2022-02-28 | 4 | Jones Jeffrey Alan | CGEM | Stock Option (Right to Buy) | D | 14.34 | 215,000 | 215,000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 13.60 | 57,000 | 57,000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 28,500 | 51,411 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Keane Raymond T | CGEM | Stock Option (Right to Buy) | D | 13.60 | 45,000 | 45,000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Keane Raymond T | CGEM | Common Stock | D | 22,500 | 24,124 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Zawel Leigh | CGEM | Stock Option (Right to Buy) | D | 13.60 | 65,000 | 65,000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Zawel Leigh | CGEM | Common Stock | D | 32,500 | 69,785 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Baeuerle Patrick | CGEM | Stock Option (Right to Buy) | D | 13.60 | 75,000 | 75,000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 37,500 | 37,500 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Trigilio Jeffrey | CGEM | Stock Option (Right to Buy) | D | 13.60 | 75,000 | 75,000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 37,500 | 39,750 | ||||||
| 2022-02-15 | 2022-02-11 | 4 | Savill Corrine | CGEM | Stock Option (Right to Buy) | D | 13.60 | 33,000 | 33,000 | |||||
| 2022-02-15 | 2022-02-11 | 4 | Savill Corrine | CGEM | Common Stock | D | 16,500 | 209,615 | ||||||
| 2022-01-13 | 2022-01-11 | 4 | F2 Vision SCS | CGEM | Common Stock | D | -1,187,734 | 1,724,611 | ||||||
| 2022-01-10 | 3 | LAMPERT MARK N | CGEM | Common Stock | D | 2,790,018 | ||||||||
| 2022-01-10 | 3 | LAMPERT MARK N | CGEM | Common Stock | D | 2,186,838 | ||||||||
| 2022-01-10 | 3 | LAMPERT MARK N | CGEM | Common Stock | D | 301,671 | ||||||||
| 2021-10-20 | 2021-10-18 | 4 | AHMED NADIM | CGEM | Stock Option (Right to Buy) | D | 21.12 | 2,710,000 | 2,710,000 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 4.30 | -4,000 | 217,978 | |||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 23.6100 | -400 | -9 | 22,911 | ||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 22.4000 | -204 | -5 | 23,311 | ||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 21.1000 | -3,396 | -72 | 23,515 | ||||
| 2021-10-20 | 2021-10-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 4,000 | 17 | 26,911 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Zawel Leigh | CGEM | Common Stock | D | 25.0000 | -19,574 | -489 | 37,285 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Trigilio Jeffrey | CGEM | Stock Option (Right to Buy) | D | 4.30 | -8,000 | 229,891 | |||||
| 2021-10-18 | 2021-10-15 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 25.0000 | -8,000 | -200 | 2,250 | ||||
| 2021-10-18 | 2021-10-15 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 4.3000 | 8,000 | 34 | 10,250 | ||||
| 2021-10-12 | 2021-10-07 | 4 | Zawel Leigh | CGEM | Common Stock | D | 25.0000 | -1,079 | -27 | 56,859 | ||||
| 2021-09-21 | 2021-09-20 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 4.30 | -4,000 | 221,978 | |||||
| 2021-09-21 | 2021-09-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 25.2000 | -800 | -20 | 22,911 | ||||
| 2021-09-21 | 2021-09-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 24.3400 | -3,200 | -78 | 23,711 | ||||
| 2021-09-21 | 2021-09-20 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 4,000 | 17 | 26,911 | ||||
| 2021-09-21 | 2021-09-20 | 4 | Zawel Leigh | CGEM | Common Stock | D | 25.1600 | -7,468 | -188 | 57,938 | ||||
| 2021-09-20 | 2021-09-16 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.0600 | -3,124 | -91 | 7,648,268 | ||||
| 2021-09-20 | 2021-09-16 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.0600 | -3,124 | -91 | 7,648,268 | ||||
| 2021-09-20 | 2021-09-16 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.0600 | -432 | -13 | 244,551 | ||||
| 2021-09-16 | 2021-09-15 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.1600 | -6,425 | -187 | 7,651,392 | ||||
| 2021-09-16 | 2021-09-14 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.1700 | -7,106 | -207 | 7,657,817 | ||||
| 2021-09-16 | 2021-09-15 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.1600 | -6,425 | -187 | 7,651,392 | ||||
| 2021-09-16 | 2021-09-15 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.1600 | -888 | -26 | 244,983 | ||||
| 2021-09-16 | 2021-09-14 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.1700 | -7,106 | -207 | 7,657,817 | ||||
| 2021-09-16 | 2021-09-14 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.1700 | -982 | -29 | 245,871 | ||||
| 2021-09-13 | 2021-09-13 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.1000 | -3,595 | -105 | 7,664,923 | ||||
| 2021-09-13 | 2021-09-10 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.0400 | -5,931 | -172 | 7,668,518 | ||||
| 2021-09-13 | 2021-09-09 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.3500 | -13,727 | -403 | 7,674,449 | ||||
| 2021-09-13 | 2021-09-13 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.1000 | -3,595 | -105 | 7,664,923 | ||||
| 2021-09-13 | 2021-09-13 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.1000 | -497 | -14 | 246,853 | ||||
| 2021-09-13 | 2021-09-10 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.0400 | -5,931 | -172 | 7,668,518 | ||||
| 2021-09-13 | 2021-09-10 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.0400 | -820 | -24 | 247,350 | ||||
| 2021-09-13 | 2021-09-09 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.3500 | -13,727 | -403 | 7,674,449 | ||||
| 2021-09-13 | 2021-09-09 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.3500 | -1,898 | -56 | 248,170 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Baeuerle Patrick | CGEM | Stock Option (Right to Buy) | D | 4.30 | -11,000 | 240,114 | |||||
| 2021-09-09 | 2021-09-08 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 28.4500 | -11,000 | -313 | 0 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 4.3000 | 11,000 | 47 | 11,000 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Trigilio Jeffrey | CGEM | Stock Option (Right to Buy) | D | 4.30 | -15,000 | 237,891 | |||||
| 2021-09-09 | 2021-09-08 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 28.8500 | -9,513 | -274 | 2,250 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 27.8300 | -5,487 | -153 | 11,763 | ||||
| 2021-09-09 | 2021-09-08 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 4.3000 | 15,000 | 64 | 17,250 | ||||
| 2021-09-08 | 2021-09-08 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.1100 | -10,842 | -316 | 7,688,176 | ||||
| 2021-09-08 | 2021-09-07 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.0400 | -25,067 | -728 | 7,699,018 | ||||
| 2021-09-08 | 2021-09-03 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.6000 | -12,731 | -377 | 7,724,085 | ||||
| 2021-09-08 | 2021-09-08 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.1100 | -10,842 | -316 | 7,688,176 | ||||
| 2021-09-08 | 2021-09-08 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.1100 | -1,499 | -44 | 250,068 | ||||
| 2021-09-08 | 2021-09-07 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.0400 | -25,067 | -728 | 7,699,018 | ||||
| 2021-09-08 | 2021-09-07 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.0400 | -3,465 | -101 | 251,567 | ||||
| 2021-09-08 | 2021-09-03 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.6000 | -12,731 | -377 | 7,724,085 | ||||
| 2021-09-08 | 2021-09-03 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.6000 | -1,760 | -52 | 255,032 | ||||
| 2021-09-08 | 2021-09-07 | 4 | Zawel Leigh | CGEM | Common Stock | D | 28.9500 | -28,118 | -814 | 65,406 | ||||
| 2021-09-02 | 2021-09-02 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.4600 | -15,757 | -464 | 7,736,816 | ||||
| 2021-09-02 | 2021-09-01 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.4700 | -5,714 | -168 | 7,752,573 | ||||
| 2021-09-02 | 2021-08-31 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 30.1400 | -1,553 | -47 | 7,758,287 | ||||
| 2021-09-02 | 2021-08-31 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.4300 | -1,285 | -38 | 7,759,840 | ||||
| 2021-09-02 | 2021-09-02 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.4600 | -15,757 | -464 | 7,736,816 | ||||
| 2021-09-02 | 2021-09-02 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.4600 | -2,178 | -64 | 256,792 | ||||
| 2021-09-02 | 2021-09-01 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.4700 | -5,714 | -168 | 7,752,573 | ||||
| 2021-09-02 | 2021-09-01 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.4700 | -790 | -23 | 258,970 | ||||
| 2021-09-02 | 2021-08-31 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 30.1400 | -1,553 | -47 | 7,758,287 | ||||
| 2021-09-02 | 2021-08-31 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 30.1400 | -215 | -6 | 259,760 | ||||
| 2021-09-02 | 2021-08-31 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.4300 | -1,285 | -38 | 7,759,840 | ||||
| 2021-09-02 | 2021-08-31 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.4300 | -177 | -5 | 259,975 | ||||
| 2021-08-31 | 2021-08-30 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.3000 | -31,001 | -908 | 7,761,125 | ||||
| 2021-08-31 | 2021-08-30 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.3000 | -4,285 | -126 | 260,152 | ||||
| 2021-08-31 | 2021-08-27 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.0900 | -13,357 | -389 | 7,792,126 | ||||
| 2021-08-31 | 2021-08-27 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.0900 | -1,846 | -54 | 264,437 | ||||
| 2021-08-31 | 2021-08-30 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.3000 | -31,001 | -908 | 7,761,125 | ||||
| 2021-08-31 | 2021-08-27 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.0900 | -13,357 | -389 | 7,792,126 | ||||
| 2021-08-26 | 2021-08-10 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 28.4900 | -1,817 | -52 | 121,642 | ||||
| 2021-08-26 | 2021-08-10 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 27.3400 | -3,191 | -87 | 123,459 | ||||
| 2021-08-26 | 2021-08-10 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 26.5000 | -1,906 | -51 | 126,650 | ||||
| 2021-08-26 | 2021-08-09 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 27.1100 | -1,700 | -46 | 128,556 | ||||
| 2021-08-26 | 2021-08-09 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 26.5200 | -19,504 | -517 | 130,256 | ||||
| 2021-08-26 | 2021-08-23 | 4/A | Zawel Leigh | CGEM | Common Stock | D | 29.0000 | -28,118 | -815 | 93,524 | ||||
| 2021-08-26 | 2021-08-18 | 4/A | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 4.30 | -4,000 | 225,978 | |||||
| 2021-08-26 | 2021-08-18 | 4/A | Michaelson Jennifer | CGEM | Common Stock | D | 28.0700 | -1,137 | -32 | 22,911 | ||||
| 2021-08-26 | 2021-08-18 | 4/A | Michaelson Jennifer | CGEM | Common Stock | D | 27.5000 | -2,863 | -79 | 24,048 | ||||
| 2021-08-26 | 2021-08-18 | 4/A | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 4,000 | 17 | 26,911 | ||||
| 2021-08-26 | 2021-08-10 | 4 | Baeuerle Patrick | CGEM | Stock Option (Right to Buy) | D | 4.30 | -11,000 | 251,114 | |||||
| 2021-08-26 | 2021-08-10 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 27.0000 | -11,000 | -297 | 0 | ||||
| 2021-08-26 | 2021-08-10 | 4 | Baeuerle Patrick | CGEM | Common Stock | D | 4.3000 | 11,000 | 47 | 11,000 | ||||
| 2021-08-25 | 2021-08-25 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.0900 | -1,713 | -50 | 7,805,483 | ||||
| 2021-08-25 | 2021-08-24 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.4800 | -50,822 | -1,498 | 7,807,196 | ||||
| 2021-08-25 | 2021-08-23 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.1100 | -53,359 | -1,553 | 7,858,018 | ||||
| 2021-08-25 | 2021-08-25 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.0900 | -1,713 | -50 | 7,805,483 | ||||
| 2021-08-25 | 2021-08-25 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.0900 | -237 | -7 | 266,283 | ||||
| 2021-08-25 | 2021-08-24 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.4800 | -50,882 | -1,500 | 7,807,196 | ||||
| 2021-08-25 | 2021-08-24 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.4800 | -7,025 | -207 | 266,520 | ||||
| 2021-08-25 | 2021-08-23 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.1100 | -53,359 | -1,553 | 7,858,018 | ||||
| 2021-08-25 | 2021-08-23 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.1100 | -7,376 | -215 | 273,545 | ||||
| 2021-08-24 | 2021-08-18 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 4.30 | -4,000 | 225,978 | |||||
| 2021-08-24 | 2021-08-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 28.0700 | -1,137 | -32 | 22,911 | ||||
| 2021-08-24 | 2021-08-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 27.5000 | -2,863 | -79 | 24,048 | ||||
| 2021-08-24 | 2021-08-18 | 4 | Michaelson Jennifer | CGEM | Common Stock | D | 4.3000 | 4,000 | 17 | 26,911 | ||||
| 2021-08-24 | 2021-08-23 | 4 | Zawel Leigh | CGEM | Common Stock | D | 29.0000 | -28,118 | -815 | 93,524 | ||||
| 2021-08-12 | 2021-08-11 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 29.0500 | -2,510 | -73 | 7,911,377 | ||||
| 2021-08-12 | 2021-08-11 | 4 | GADICKE ANSBERT | CGEM | Common Stock | I | 29.0500 | -2,510 | -73 | 7,911,377 | ||||
| 2021-08-12 | 2021-08-11 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 29.0500 | -347 | -10 | 280,921 | ||||
| 2021-08-11 | 2021-08-10 | 4 | Zawel Leigh | CGEM | Common Stock | D | 28.4900 | -1,817 | -52 | 121,642 | ||||
| 2021-08-11 | 2021-08-10 | 4 | Zawel Leigh | CGEM | Common Stock | D | 27.3400 | -3,191 | -87 | 123,459 | ||||
| 2021-08-11 | 2021-08-10 | 4 | Zawel Leigh | CGEM | Common Stock | D | 26.5000 | -1,906 | -51 | 126,650 | ||||
| 2021-08-11 | 2021-08-09 | 4 | Zawel Leigh | CGEM | Common Stock | D | 27.1100 | -1,700 | -46 | 128,556 | ||||
| 2021-08-11 | 2021-08-09 | 4 | Zawel Leigh | CGEM | Common Stock | D | 26.5200 | -19,504 | -517 | 130,256 | ||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Series C Convertible Preferred Stock | D | -649,030 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Series B Convertible Preferred Stock | D | -2,276,692 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Series A Convertible Preferred Stock | D | -3,551,640 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Series Seed Convertible Preferred Stock | D | -1,136,525 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 21.0000 | 300,000 | 6,300 | 7,913,887 | ||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 649,030 | 7,613,887 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 2,276,692 | 6,964,857 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 3,551,640 | 4,688,165 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | UBS Oncology Impact Fund L.P. | CGEM | Common Stock | D | 1,136,525 | 1,136,525 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series C Convertible Preferred Stock | I | -649,030 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series B Convertible Preferred Stock | I | -2,276,692 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series A Convertible Preferred Stock | I | -3,551,640 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series Seed Convertible Preferred Stock | I | -1,136,525 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 21.0000 | 300,000 | 6,300 | 7,913,887 | ||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 649,030 | 7,613,887 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 2,276,692 | 6,964,857 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 3,551,640 | 4,688,165 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | GADICKE ANSBERT See footnotes | CGEM | Common Stock | I | 1,136,525 | 1,136,525 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT | CGEM | Stock Option (Right to Buy) | D | 4.30 | 88,824 | 88,824 | |||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT | CGEM | Stock Option (Right to Buy) | D | 4.30 | 262,114 | 262,114 | |||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series C Convertible Preferred Stock | I | 649,030 | 649,030 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series B Convertible Preferred Stock | I | 2,276,692 | 2,276,692 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series A Convertible Preferred Stock | I | 3,551,640 | 3,551,640 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT See footnotes | CGEM | Series Seed Convertible Preferred Stock | I | 1,136,525 | 1,136,525 | ||||||
| 2021-01-14 | 2021-01-07 | 4 | GADICKE ANSBERT | CGEM | Common Stock | D | 281,268 | 281,268 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series C Convertible Preferred Stock | I | -1,511,966 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series C Convertible Preferred Stock | I | -503,988 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series C Convertible Preferred Stock | I | -503,988 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series C Convertible Preferred Stock | I | -1,007,977 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series B Convertible Preferred Stock | I | -1,282,051 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series B Convertible Preferred Stock | I | -3,205,128 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series A Convertible Preferred Stock | I | -4,500,000 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series A Convertible Preferred Stock | I | -20,500,000 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Series Seed Convertible Preferred Stock | I | -8,000,000 | 0 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 21.0000 | 104,762 | 2,200 | 104,762 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 21.0000 | 95,238 | 2,000 | 622,175 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 214,798 | 214,798 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 71,599 | 71,599 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 71,599 | 71,599 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 143,198 | 325,333 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 182,135 | 182,135 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 455,338 | 455,338 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 639,295 | 639,295 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 2,912,345 | 2,912,345 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Jovan-Embiricos Morana | CGEM | Common Stock | I | 1,136,525 | 1,136,525 | ||||||
| 2021-01-14 | 2021-01-12 | 4 | Trigilio Jeffrey | CGEM | Common Stock | D | 21.0000 | 2,250 | 47 | 2,250 | ||||
| 2021-01-14 | 2021-01-12 | 4 | Hughes Owen | CGEM | Common Stock | D | 21.0000 | 2,500 | 52 | 506,226 | ||||
| 2021-01-11 | 2021-01-07 | 4 | Baeuerle Patrick | CGEM | Stock Option (Right to Buy) | D | 21.00 | 286,665 | 286,665 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Zawel Leigh | CGEM | Stock Option (Right to Buy) | D | 21.00 | 56,666 | 56,666 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Michaelson Jennifer | CGEM | Stock Option (Right to Buy) | D | 21.00 | 79,999 | 79,999 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Hughes Owen | CGEM | Stock Option (Right to Buy) | D | 21.00 | 433,332 | 433,332 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Trigilio Jeffrey | CGEM | Stock Option (Right to Buy) | D | 21.00 | 146,665 | 146,665 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Wigginton Jon Marc | CGEM | Stock Option (Right to Buy) | D | 21.00 | 116,666 | 116,666 | |||||
| 2021-01-11 | 2021-01-07 | 4 | Keane Raymond T | CGEM | Stock Option (Right to Buy) | D | 21.00 | 249,998 | 249,998 | |||||
| 2021-01-07 | 3 | Michaelson Jennifer | CGEM | Common Stock | D | 22,911 | ||||||||
| 2021-01-07 | 3 | Rosenberg Anthony | CGEM | Common Stock | D | 45,002 | ||||||||
| 2021-01-07 | 3 | Ebeling Thomas | CGEM | Common Stock | D | 67,504 | ||||||||
| 2021-01-07 | 3 | Zawel Leigh | CGEM | Common Stock | D | 149,760 | ||||||||
| 2021-01-07 | 3 | GADICKE ANSBERT | CGEM | Common Stock | D | 281,268 | ||||||||
| 2021-01-07 | 3 | Baeuerle Patrick | CGEM | Common Stock | I | 341,434 | ||||||||
| 2021-01-07 | 3 | Keane Raymond T | CGEM | Common Stock | D | 1,624 | ||||||||
| 2021-01-07 | 3 | F2 MC, LLC | CGEM | Common Stock | D | 112,507 | ||||||||
| 2021-01-07 | 3 | Hughes Owen | CGEM | Common Stock | D | 503,726 | ||||||||
| 2021-01-07 | 3 | Savill Corrine | CGEM | Common Stock | D | 193,115 |
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)
